Younger-Looking Brains Linked To Better VNS Outcomes
Researchers built a “brain-age” tool from structural MRI scans.
This hub covers drug-resistant epilepsy: When seizures aren’t controlled after trying two appropriate medicines. Research-backed next steps on diet therapies, devices, surgery evaluation, and safety.
If seizures aren’t controlled after two meds, it’s worth at least an evaluation at an epilepsy center.
Not necessarily. Some familiar consider it earlier depending on seizure type and goals.
Yes. Treatment response can change over time, and combinations/approaches matter.
Seizure frequency, triggers, sleep, missed meds, side effects, and rescue med use.
Researchers built a “brain-age” tool from structural MRI scans.
This paper combined results from 13 studies on ketogenic dietary therapies (KDT) for refractory epilepsy in Latin America.
This paper was a systematic review, which means the authors searched for and combined results from earlier studies rather than testing a new device themselves.
This study looked at how low-grade epilepsy-associated brain tumors (LEATs) are currently managed across Europe.
This study looked at whether intravenous immunoglobulin, called IVIG, might help children with drug-resistant epilepsy.
This exploratory pilot study looked at whether certain MRI features of a brain malformation called focal cortical dysplasia type II (FCD II) were linked with neuropsychological functioning in children and teens with pharmacoresistant epilepsy.
This paper was a systematic review with pooled analysis of studies on deep brain stimulation (DBS) in the thalamus for adults with drug-resistant epilepsy.
This study looked at how people with epilepsy in Germany were treated and referred through the healthcare system.
This retrospective cohort study looked at children with super refractory status epilepticus (SRSE) who were started on the ketogenic diet at one center from 2009 to 2024.